{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:45:51Z","timestamp":1774939551956,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":6021,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.fertnstert.2005.06.026","type":"journal-article","created":{"date-parts":[[2005,12,16]],"date-time":"2005-12-16T10:08:10Z","timestamp":1134727690000},"page":"1685-1688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["M\u00fcllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B"],"prefix":"10.1016","volume":"84","author":[{"given":"Micheline C.","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Carmina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogerio A.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2005.06.026_bib1","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-Mullerian hormone levels","volume":"17","author":"van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib4","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/humrep\/deh373","article-title":"Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility","volume":"19","author":"Mulders","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(97)81417-3","article-title":"Mullerian-inhibiting substance in follicular fluid and serum","volume":"67","author":"Fallat","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women","volume":"77","author":"Cook","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib8","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","article-title":"Mullerian-inhibiting substance in women with polycystic ovary syndrome","volume":"82","author":"La Marca","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2003.09.024","article-title":"Anti-Mullerian hormone and its role in ovarian function","volume":"211","author":"Gruijters","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib10","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2265.1998.00442.x","article-title":"Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation","volume":"48","author":"Anderson","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib12","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1210\/jcem.83.5.4756","article-title":"Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy","volume":"83","author":"Lockwood","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib13","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0015-0282(00)00421-0","article-title":"Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome","volume":"73","author":"Pigny","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/16.7.1359","article-title":"Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility","volume":"16","author":"Laven","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/humrep\/16.4.668","article-title":"Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib16","first-page":"45","article-title":"Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay","volume":"79","author":"Lambert-Messerlian","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib17","first-page":"1589","volume":"86","author":"Elting","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(85)92552-8","article-title":"Multifollicular ovaries","volume":"2","author":"Adams","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib20","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0002-9378(91)90042-P","article-title":"Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?","volume":"165","author":"Stanczyk","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0002-9378(80)90079-4","article-title":"Prolactin modulation of dehydroepiandrosterone sulfate secretion","volume":"138","author":"Lobo","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib22","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fertnstert.2004.05.098","article-title":"Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment","volume":"83","author":"Fleming","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.06.026_bib24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1067\/S0002-9378(03)00832-9","article-title":"Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?","volume":"189","author":"Carmina","year":"2003","journal-title":"Am J Obstet Gynecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028205029420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028205029420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:09:50Z","timestamp":1758006590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028205029420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0015028205029420"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2005.06.026","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00fcllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2005.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}